PT  - JOURNAL ARTICLE
AU  - Mao, Xuanyu
AU  - Liu, Xiao-Ping
AU  - Xiong, Miao
AU  - Yang, Xu
AU  - Jin, Xiaoqing
AU  - Li, Zhiqiang
AU  - Zhou, Shuang
AU  - Chang, Hang
TI  - Development and validation of chest CT-based imaging biomarkers for early stage COVID-19 screening
AID  - 10.1101/2020.05.15.20103473
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.15.20103473
4099  - http://medrxiv.org/content/early/2020/06/03/2020.05.15.20103473.short
4100  - http://medrxiv.org/content/early/2020/06/03/2020.05.15.20103473.full
AB  - Coronavirus Disease 2019 (COVID-19) is currently a global pandemic, and the early screening of COVID-19 is one of the key factors for COVID-19 control and treatment. Here, we developed and validated chest CT-based imaging biomarkers for COVID-19 patient screening. We identified the vasculature-like signals from CT images and found that, compared to healthy and community acquired pneumonia (CAP) patients, the COVID-19 patients revealed significantly higher abundance of these signals. Furthermore, unsupervised feature learning leads to the discovery of clinical-relevant imaging biomarkers from the vasculature-like signals for accurate and sensitive COVID-19 screening that has been double-blindly validated in an independent hospital (sensitivity: 0.941, specificity: 0.904, AUC: 0.952). Our findings could open a new avenue to assist screening of COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study has been approved by the institutional review board (IRB) of both participating hospitalsAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe 3D imaging biomarkers and the pre-trained Stacked PSD model are available at http://bmihub.org/project/covid19-imaging-biomarkers. The raw chest CT cohorts involved in this study were not publicly available due to the DICOM metadata containing information that could compromise patient privacy/consent. http://bmihub.org/project/covid19-imaging-biomarkers